Cisplatin (Synonyms: 順鉑; cis-Platinum; CDDP; cis-Diaminodichloroplatinum)

目錄號(hào): HY-17394 純度: ≥99.0%: Data Sheet SDS COA 產(chǎn)品使用指南
FAQs
技術(shù)支持

Cisplatin (CDDP) 是一種抗腫瘤的化療劑，它與 DNA 交聯(lián)引起癌細(xì)胞中 DNA 損傷。Cisplatin 可激活鐵死亡 (ferroptosis) 并誘導(dǎo)自噬 (autophagy)。

MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào)，我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)

CAS No. : 15663-27-1

1. 客戶無(wú)需承擔(dān)相應(yīng)的運(yùn)輸費(fèi)用。

2. 同一機(jī)構(gòu)（單位）同一產(chǎn)品試用裝僅限申領(lǐng)一次，同一機(jī)構(gòu)（單位）一年內(nèi)

可免費(fèi)申領(lǐng)三個(gè)不同產(chǎn)品的試用裝。

3. 試用裝只面向終端客戶。

規(guī)格	價(jià)格	是否有貨
5 mg	￥100	In-stock
10 mg	￥140	In-stock
50 mg	￥280	In-stock
100 mg	￥420	In-stock
500 mg	￥1100	In-stock
1 g	￥1870	In-stock
5 g		詢價(jià)
10 g		詢價(jià)

or 大包裝詢價(jià)

* Please select Quantity before adding items.

Customer Review

MCE 顧客使用本產(chǎn)品發(fā)表的 578 篇科研文獻(xiàn)

•Nature. 2025 Apr;640(8060):1062-1071. [Abstract]
•Mol Cancer. 2024 Oct 31;23(1):243. [Abstract]
•Bioact Mater. 2024 May 11:38:384-398. [Abstract]
•Mol Cancer. 2024 Jan 10;23(1):12. [Abstract]
•Drug Resist Updat. 2024 Mar:73:101059.
•Cell Res. 2023 Jul 17. [Abstract]

•Cancer Discov. 2023 May 4;CD-22-1315. [Abstract]
•Adv Mater. 2023 May 6;e2300602. [Abstract]
•Adv Mater. 2023 Jan 19;e2210787. [Abstract]
•Nat Cancer. 2022 Oct;3(10):1211-1227. [Abstract]
•Signal Transduct Target Ther. 2022 Sep 12;7(1):317. [Abstract]
•J Hematol Oncol. 2021 Oct 29;14(1):178. [Abstract]
•Mol Cancer. 2021 Apr 4;20(1):62. [Abstract]
•Cell Metab. 2021 May 4;33(5):988-1000.e7. [Abstract]
•Signal Transduct Target Ther. 2020 May 20;5(1):56. [Abstract]
•Eur Urol. 2020 Nov 2;S0302-2838(20)30778-8. [Abstract]
•Cancer Discov. 2017 Sep;7(9):984-998. [Abstract]
•Nat Commun. 2025 May 23;16(1):4793. [Abstract]
•Cell Death Differ. 2025 Apr 9. [Abstract]
•Cell Death Differ. 2025 Mar 25. [Abstract]
•Nat Commun. 2025 Jan 31;16(1):1233. [Abstract]
•Nat Commun. 2025 Jan 9;16(1):541. [Abstract]
•ACS Nano. 2024 Oct 30. [Abstract]
•Nat Commun. 2024 Sep 10;15(1):7923. [Abstract]
•Cell Death Differ. 2024 Sep 22. [Abstract]
•Nat Commun.2024 May 23;15(1):4383. [Abstract]
•Adv Funct Mater. 2023 Apr 14.
•Mol Cell. 2023 Feb 25;S1097-2765(23)00083-7. [Abstract]
•Nat Commun. 2022 Nov 8;13(1):6740. [Abstract]
•Cell Death Differ. 2022 Sep 14. [Abstract]
•Mol Cell. 2020 Aug 6;79(3):425-442.e7. [Abstract]
•Nat Commun. 2019 Dec 2;10(1):5492. [Abstract]
•Nat Commun. 2019 Aug 21;10(1):3761. [Abstract]
•Cancer Res. 2018 Oct 1;78(19):5694-5705. [Abstract]
•Adv Sci (Weinh). 2025 Apr 24:e2501934.
•Adv Sci (Weinh). 2025 May 20:e01042.
•Research (Wash D C). 2025 May 23:8:0708.
•Research (Wash D C). 2025 May 23:8:0703.
•MedComm (2020). 2025 Apr 29;6(5):e70155.
•Cell Rep Med. 2025 Apr 2:102053. [Abstract]
•Bone Res. 2025 Feb 24;13(1):25. [Abstract]
•Cell Discov. 2025 Mar 11;11(1):22. [Abstract]
•Adv Sci (Weinh). 2024 Nov 3:e2406688. [Abstract]
•Adv Sci (Weinh). 2024 Nov 28:e2407519. [Abstract]
•Adv Sci (Weinh). 2024 Dec 16:e2412233. [Abstract]
•Microbiome. 2025 Jan 27;13(1):27. [Abstract]
•J Nanobiotechnology. 2025 Jan 15;23(1):14. [Abstract]
•J Control Release. 2025 Jan 8:379:45-58. [Abstract]
•Biomaterials. 2024 Oct 29:315:122924. [Abstract]
•Sci Adv. 2024 Sep 6.
•Adv Sci (Weinh). 2024 Aug 23:e2400156. [Abstract]
•Carbohydr Polym. 2024 Dec 15:346:122645. [Abstract]
•Adv Sci (Weinh). 2024 Aug 9:e2404693. [Abstract]
•J Immunother Cancer. 2024 Aug 6;12(8):e009024. [Abstract]
•Pharmacol Res. 2021 Sep:171:105574. [Abstract]
•Acta Pharm Sin B. 2024 Jun 28.
•Adv Sci (Weinh). 2024 Jul 14:e2308890. [Abstract]
•Adv Sci (Weinh). 2024 Jun 27:e2404668. [Abstract]
•Adv Sci (Weinh). 2024 Jul 8:e2400140. [Abstract]
•Chem Eng J. 2024 Sep 15.
•J Biomed Sci. 2024 May 13;31(1):50. [Abstract]
•Pharmacol Res. 2024 May 9:204:107208. [Abstract]
•Mater Today Bio. 2024 Jun, 26, 101053.
•J Clin Invest. 2024 Mar 7:e172716. [Abstract]
•J Exp Clin Cancer Res. 2024 Mar 12;43(1):77. [Abstract]
•EBioMedicine. 2023 Dec 14:99:104920. [Abstract]
•Redox Biol. 2023 Oct 16, 102931.
•Adv Sci (Weinh). 2023 Sep 13;e2300864. [Abstract]
•J Exp Clin Cancer Res. 2023 Sep 4;42(1):228. [Abstract]
•Adv Sci (Weinh). 2023 Jul 23;e2302640. [Abstract]
•J Adv Res. 2023 Jul 20;S2090-1232(23)00199-6. [Abstract]
•Sci Adv. 2023 Jun 2;9(22):eadc9273. [Abstract]
•Gut Microbes. 2023 Jan-Dec;15(1):2197836. [Abstract]
•Cancer Lett. 2023 Feb 15;558:216092. [Abstract]
•Cell Rep Med. 2023 Jan 10;100911. [Abstract]
•Autophagy. 2022 Nov 30;1-18. [Abstract]
•Bioengineering & Translational Medicine. 2022: e10472.
•Cancer Lett. 2022 Dec 2;216012. [Abstract]
•J Control Release. J Control Release [Abstract]
•J Exp Clin Cancer Res. 2022 Oct 5;41(1):293. [Abstract]
•Adv Sci (Weinh). 2022 Oct;9(30):e2201210. [Abstract]
•Adv Sci (Weinh). 2022 Aug 28;e2203173. [Abstract]
•Chem Eng J. 1 January 2023, 138972.
•J Immunother Cancer. 2022 Aug;10(8):e004006. [Abstract]
•Adv Sci (Weinh). 2022 Aug 17;e2201889. [Abstract]
•J Exp Clin Cancer Res. 2022 Apr 7;41(1):129. [Abstract]
•Cancer Lett. 2022 Jun 28;536:215651. [Abstract]
•Pharmacol Res. 2022 Jan 5;106059. [Abstract]
•J Exp Med. 2022 Jan 3;219(1):e20210789. [Abstract]
•Cancer Lett. 2021 Sep 21;S0304-3835(21)00464-X. [Abstract]
•Acta Pharm Sin B. 28 August 2021.
•J Immunother Cancer. 2021 Jul;9(7):e001758. [Abstract]
•Pharmacol Res. 2021, 105574.
•Theranostics. 2021 Apr 15;11(13):6278-6292. [Abstract]
•J Exp Clin Cancer Res. 2021 Apr 30;40(1):150. [Abstract]
•Theranostics. 2021 Mar 24;11(12):5650-5674. [Abstract]
•J Exp Clin Cancer Res. 2020 Aug 27;39(1):170. [Abstract]
•Acta Pharm Sin B. 2020 June 29.
•Theranostics. 2020 Apr 27;10(13):5829-5844. [Abstract]
•Theranostics. 2020 Feb 10;10(8):3488-3502. [Abstract]
•Theranostics. 2020 Mar 25;10(10):4627-4643. [Abstract]
•Theranostics. 2020 Jan 22;10(6):2553-2570. [Abstract]
•Theranostics. 2019 Oct 22;9(26):8377-8391. [Abstract]
•Mol Ther Nucleic Acids. 2019 Feb 26;16:257-271. [Abstract]
•J Exp Clin Cancer Res. 2018 Nov 27;37(1):287. [Abstract]
•Cell Death Dis. 2025 May 3;16(1):358.
•Cell Commun Signal. 2025 May 3;23(1):213.
•Cancer Immunol Res. 2025 May 22.
•Cell Death Dis. 2025 Apr 11;16(1):274. [Abstract]
•Acta Pharmacol Sin. 2025 Apr 17.
•Phytomedicine. 2025 Mar 14.
•Genes Dis. 2025 Jan 7.
感谢您访问我们的网站，您可能还对以下资源感兴趣：
天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口
美乐家奖金制度,3da显卡模拟器,初中读书手抄报一等奖,开奖号查询日韩中文字幕免费观看,狠狠色丁香久久婷婷综合丁香,91在线视频免费看,蜜桃视频在线亚洲色p,快活影院在线毛片,婷婷六月丁香色婷婷网,你懂的视频在线观看国产91精品在线观看,成人一区专区在线观看,中文字幕网站在线观看,在线播放免费人成毛片试看中文性按摩1区2区3区,国产网站在线看,八戒影视在线观看免费,四虎国产精品高清在线观看毛片特级,美女撒尿毛片免费看,久久大尺度,人人玩人人添人人澡免费

天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Cisplatin (Synonyms: 順鉑; cis-Platinum; CDDP; cis-Diaminodichloroplatinum)

Customer Review

Cisplatin 相關(guān)抗體

MCE 顧客使用本產(chǎn)品發(fā)表的 578 篇科研文獻(xiàn)